US 8946409
Polycyclic β lactam derivatives for the treatment of cancer
granted A61PA61P35/00
Quick answer
US patent 8946409 (Polycyclic β lactam derivatives for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P35/00